Publications Database

Aman M. G. et al. (2010)

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(5), pp. 415-422.

Read Abstract (New Window)

Aman M. G. et al. (2009)

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial.

Journal of the American Academy of Child and Adolescent Psychiatry

48(12), pp. 1143-1154

Read Abstract (New Window) Read Full (New Window)

Aman M. G. , Hollway J. A. , Arnold L. E. (2008)

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 713-738

Read Abstract (New Window)

American Society of Health-System Pharmacists (2017)

Aripiprazole.

American Society of Health-System Pharmacists

Read Full (New Window)

Anagnostou E.

Clinical trials in autism spectrum disorder: evidence, challenges and future directions.

Current Opinion in Neurology

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

An update on medication management of behavioral disorders in autism.

Current Psychiatry Reports

16(3), pp. 437

Read Abstract (New Window)

Basgul S. S. (2014)

Aripiprazole use in children and adolescents: A public hospital child psychiatry outpatient department’s experience.

Bulletin of Clinical Psychopharmacology

24(1), pp. 31-8

Blankenship K. et al. (2010)

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Pediatric Health

4(4), pp. 375-381

Read Abstract (New Window) Read Full (New Window)

Caccia S. (2013)

Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.

Pediatric Drugs

15(3), pp. 217-233.

Read Abstract (New Window)

Caldwell R. L. et al. (2012)

The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders.

Research in Autism Spectrum Disorders

August, 22(4), pp. 277-283.

Read Abstract (New Window) Read Full (New Window)

Chavez B. et al. (2007)

Atypical antipsychotics in children with pervasive developmental disorders.

Pediatric Drugs

9(4), pp. 249-266

Read Abstract (New Window)

Ching H. , Pringsheim T. (2012)

Aripiprazole for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

Read Abstract (New Window) Read Full (New Window)

Cohen D. et al. (2013)

Risperidone or aripiprazole in children and adolescents with autism and/or intellectual disability: A Bayesian meta-analysis of efficacy and secondary effects.

Research in Autism Spectrum Disorders

7(1), pp. 167-175.

Read Abstract (New Window)

Coury D. (2011)

Review: little evidence of clear benefit for most medical treatments for children with autism spectrum disorders.

Evidence Based Mental Health

May, 127(5),

Read Abstract (New Window) Read Full (New Window)

Curran M. (2011)

Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.

Pediatric Drugs

13(3), pp. 197-204

Read Abstract (New Window)

Deb S. et al. (2014)

The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder: A systematic review.

Research in Developmental Disabilities

March, 35(3), pii: S0891-4222(13)00547-7

Read Abstract (New Window)

Douglas-Hall P. et al.

Aripiprazole: A review of its use in the treatment of irritability associated with autistic disorder patients aged 6–17.

3 pp. 143-153.

Read Abstract (New Window) Read Full (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Dialogues in Clinical Neuroscience

14(3), pp. 263-279.

Read Abstract (New Window) Read Full (New Window)

Elbe D. , Lalani Z. (2012)

Review of the pharmacotherapy of irritability of autism.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

21(2), pp. 130-146.

Read Abstract (New Window) Read Full (New Window)

Erickson C. A. et al. (2011)

A prospective open-label study of aripiprazole in fragile X syndrome.

Psychopharmacology (Berl)

July, 216(1), pp. 85-90.

Read Abstract (New Window)